A biomarker is a measurable biological parameter that acts as an indicator of the underlying diseases mechanism. Researchers are undertaking significant efforts to identify novel biomarkers for early intervention and enhanced diagnosis for better diseases management. Biological biomarkers not only help comprehend clinical diagnosis but mediate the development of innovative diseases-controlling therapies.
Biomarkers differentiating between diseases-affected and healthy individuals are relatively inadequate for the diagnosis of neurodegenerative diseases. Development of biomarkers and novel assays enabling demarcation of neurodegenerative diseases with overlapping phenotypes is critical and of high relevance, particularly in the early stages of disease when the diagnosis is challenging but treatment potential is the highest.
A biomarker is a measurable biological parameter that acts as an indicator of the underlying diseases mechanism. Researchers are undertaking significant efforts to identify novel biomarkers for early intervention and enhanced diagnosis for better diseases management. Biological biomarkers not only help comprehend clinical diagnosis but mediate the development of innovative diseases-controlling therapies.
Biomarkers differentiating between diseases-affected and healthy individuals are relatively inadequate for the diagnosis of neurodegenerative diseases. Development of biomarkers and novel assays enabling demarcation of neurodegenerative diseases with overlapping phenotypes is critical and of high relevance, particularly in the early stages of disease when the diagnosis is challenging but treatment potential is the highest.